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Summary
A dynamic treatment regimen (DTR) is a pre-specified sequence of decision rules which maps
baseline or time-varying measurements on an individual to a recommended intervention or set of
interventions. Sequential multiple assignment randomized trials (SMARTs) represent an impor-
tant data collection tool for informing the construction of effective DTRs. A common primary
aim in a SMART is the marginal mean comparison between two or more of the DTRs embedded
in the trial. This manuscript develops a mixed effects modeling and estimation approach for these
primary aim comparisons based on a continuous, longitudinal outcome. The method is illustrated
using data from a SMART in autism research.
Key words: Adaptive interventions; Sequential multiple assignment randomized trials; SMART; causal
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1. Introduction
A dynamic treatment regimen (DTR) is a pre-specified sequence of decision rules which map
baseline and time-varying measurements on an individual to a recommended set of interventions
(Chakraborty and Moodie, 2013; Orellana and others, 2010; Herna´n and others, 2006; Murphy
and others, 2001). DTRs are designed to assist clinicians with ongoing care decisions based on dis-
ease progress, treatment history, and other information collected during the course of treatment.
∗To whom correspondence should be addressed.
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DTRs are also known as adaptive treatment strategies (Kosorok and Moodie, 2015; Murphy and
others, 2007) or adaptive interventions (Almirall and others, 2014; Nahum-Shani and others,
2012).
A sequential, multiple assignment randomized trial (SMART) is a multi-stage trial design
specifically created for comparing or constructing DTRs (Lavori and Dawson, 2014; Lei and
others, 2012; Murphy, 2005). Study participants in a SMART may experience multiple random-
izations. These randomizations occur at decision points for which there is a question about which
treatment to provide. By the end of the trial, specific groups of study participants will have been
subject to the sequence of treatment decisions corresponding to at least one of a pre-specified set
of DTRs. SMARTs enable causal comparisons among these “embedded” DTRs.
In this article we focus on scientific questions which involve comparing the embedded DTRs
in a SMART based on the mean of a continuous, longitudinal outcome. Often this is a primary
scientific aim in a SMART (Seewald and others, 2018). One way of answering these questions
involves directly specifying a model for the marginal mean of the longitudinal outcome under
each DTR and estimating the parameters in that model using weighted estimating equations (Lu
and others, 2016; Seewald and others, 2018). Similar methods are available when the longitudinal
outcome is binary (Dziak and others, 2019), for a survival outcome (Li and Murphy, 2011), and
for clustered SMARTs where the embedded DTRs are applied to clusters of people but outcomes
are measured on individuals within each cluster (NeCamp and others, 2017).
The purpose of this article is to develop linear mixed effects models for primary aim com-
parisons of the embedded DTRs in a SMART with a continuous, longitudinal outcome. Mixed
effects models are a well established tool for analyzing longitudinal, clustered, or multilevel data
in the medical, social, and agricultural sciences (Fitzmaurice and others, 2012; Raudenbush and
Bryk, 2002; Snijders and Bosker, 2012; Searle and others, 2006; Goldstein, 2011; Hedeker and
Gibbons, 2006). This paper provides a way for researchers to analyze data from SMARTs using
these familiar statistical tools. In addition, we see at least three reasons why scientists might
prefer mixed effects models when analyzing SMARTs.
First, mixed models provide an intuitive, flexible way to model within-person correlations
among longitudinal outcomes. Existing statistical methods for SMARTs with a continuous, lon-
gitudinal outcome (Lu and others, 2016; Seewald and others, 2018) involve directly specifying
a working model for the marginal covariance matrix of the repeated measures, as in generalized
estimating equations (GEE, Liang and Zeger (1986)). In contrast, our mixed effects model in-
directly parameterizes the marginal covariance using random effects—latent random variables
which describe subject-specific change over time. This specification distinguishes within-subject
and between-subject variation and provides an intuitive and flexible way to model the marginal
covariance as a function of time and other covariates.
Second, modeling the within-person correlation among longitudinal measurements can im-
prove statistical efficiency in estimating regression parameters (e.g. Diggle and others, 2002,
Section 4.6), and mixed models easily parameterize rich covariance functions using few param-
eters, regardless of the number or spacing of measurement occasions (Fitzmaurice and others
(2012, Chapter 8), Hedeker and Gibbons (2006, Chapter 8)).
Third, mixed models provide predictions of subject-specific outcome trajectories via prediction
of the random effects (Skrondal and Rabe-Hesketh (2009), Hedeker and Gibbons (2006, Chapter
4), Searle and others (2006, Chapter 7)). While such predictions do not constitute the primary
aim of comparing embedded DTRs in a SMART, they may be useful in understanding the type
and magnitude of heterogeneity in person-specific change with respect to the embedded DTRs
and in identifying individuals with unusual response trajectories.
Throughout this paper we will refer to an example SMART designed to compare three DTRs
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for improving spoken language in children with autism. Section 2 introduces this study design
and provides a general description of SMARTs and embedded DTRs. Section 3 introduces our
proposed mixed model for comparing embedded DTRs in a SMART and Section 4 describes
how we estimate parameters and predict random effects in this model. In Section 5 we report the
results of simulation experiments which investigate the operating characteristics of our estimation
method, and in Section 6 we illustrate the method using data from the autism SMART introduced
in Section 2.
2. Sequential, Multiple-Assignment Randomized Trials
Sequential, multiple assignment randomized trials (SMARTs) are multi-stage randomized trial
designs which were developed explicitly for the purpose of building high-quality DTRs (Murphy,
2005; Lavori and Dawson, 2000; Dawson and Lavori, 2008). Each participant in a SMART may
move through multiple stages of treatment, and the defining feature of a SMART is that some
or all participants are randomized at more than one decision point. At each decision point, the
purpose of randomization is to address a question concerning the dosage intensity, type, or delivery
of treatment at that decision point. A common primary aim in a SMART is the marginal mean
comparison of two or more embedded DTRs on a longitudinal research outcome. The following
example SMART illustrates these ideas.
2.1 An Example SMART in Autism
The SMART shown in Figure 1 (Kasari and others, 2014) involved N = 61 children, between
five and eight years old, who had a previous diagnosis of autism spectrum disorder and were
considered “minimally verbal” (used fewer than 20 spontaneous different words during a baseline
20-minute language test). All eligible children were initially randomized, with equal probability,
to a behavioral treatment, called JASP, or to JASP together with a speech-generating device,
called AAC (augmentative or alternative communication). Both of these first-stage treatment
arms in the SMART involved twice-weekly sessions with a trained language therapist. The first-
stage JASP+AAC arm required that the AAC device was used at least 50 percent of the time
during these sessions.
At the end of the first treatment stage, which lasted 12 weeks, all children were classified as
“responders” or “slow responders”. Response was defined, prior to the trial, as an improvement
of at least 25 percent on seven or more language measures (e.g. words used per minute) by the
end of week 12. Children who did not satisfy this criterion were considered slow responders.
The second-stage treatments were determined as follows. Responders to the initial intervention
were continued on that intervention for an additional 12 weeks. Slow responders to JASP+AAC
were offered intensified JASP+AAC, which involved increasing the number of weekly sessions
from two to three. Slow responders to JASP were re-randomized, with equal probability, to ei-
ther intensified JASP or to JASP+AAC. The status of “responder” or “slow responder” in this
SMART is known as an embedded tailoring variable, since it is used to restrict subsequent ran-
domizations and is therefore a part of the embedded DTRs. The primary research outcome in
this SMART was the total number of spontaneous socially communicative utterances in a 20-
minute language sample, measured by an independent evaluator who was blind to the assigned
treatment sequence. This primary outcome was measured four times: prior to the initial random-
ization (baseline), prior to the second randomization (at week 12), at the end of treatment (week
24) and at a follow-up assessment (week 36).
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2.2 Dynamic Treatment Regimens Embedded in a SMART
A dynamic treatment regimen (DTR) is a sequence of decisions rules that, for all individuals
in a population of interest, guides the provision of treatment at each decision point based on
information known up to that decision point. In the case of the autism SMART, a DTR is a
sequence of decision rules that guides the first and second treatment decisions for both responders
and slow responders.
Specifically, the autism SMART has three DTRs embedded within it. These are listed in
Table 1. The DTR labeled (AAC, AAC+) starts with JASP and AAC, continues this treatment
for responders and intensifies this treatment for slow responders. The other two DTRs start with
JASP only. For slow responders, (JASP, JASP+) intensifies JASP alone while (JASP, AAC)
augments JASP with AAC. Many SMARTs use a two-stage design in which only slow responders
are randomized at the start of the second stage (Kidwell, 2014; Gunlicks-Stoessel and others,
2016, e.g.). In this SMART, however, second-stage randomization was restricted based on a
combination of first-stage treatment and response status. We use (a1, a2) to index the DTRs
embedded in the SMART, where aj denotes the treatment provided at the jth decision point.
Table 1 enumerates the values of (a1, a2) for each DTR in the autism SMART.
3. Linear Mixed Models for Comparing Embedded DTRs
We aim to develop a linear mixed model for primary aim comparisons based on a pre-specified
summary of the mean outcome under each DTR in a SMART. To do this, we use the potential
outcomes framework to describe the sequence of primary outcome measurements as a function
of the embedded DTRs. For simplicity, we focus on two-stage designs. With slight changes in
notation, the methodology presented here may be generalized to more complex SMART designs.
3.1 Potential outcomes and observed data
For each embedded DTR, indexed by (a1, a2) where a1, a2 ∈ {−1,+1}, and for the ith SMART
participant, i = 1, . . . , N , let Yi(a1, a2) = (Yiti1(a1, a2), Yiti2(a1, a2), . . . , Yitini (a1, a2))
ᵀ denote
the vector of ni time-ordered, potential outcome repeated measures. The vector Yi(a1, a2) is sim-
ply the set of longitudinal potential outcomes for participant i under DTR (a1, a2). For example,
in the case of the autism SMART, each participant has three potential values of Yi(a1, a2), cor-
responding to the three values for (a1, a2) given in Table 1. Note that in the autism study, a2
is undefined for the DTR beginning with JASP+AAC, since that DTR is fully characterized by
a1 = −1 (slow responders to JASP+AAC were not re-randomized). Let Ri(a1) ∈ {0, 1} be the
potential outcome for the binary embedded tailoring variable under first-stage treatment a1.
During the conduct of a SMART, we collect the following observed data: Yitij , the observed
primary outcome for participant i at time point tij ; Ri, the ith participant’s observed binary
tailoring variable; Li, a pre-specified vector of baseline covariates collected prior to the first
randomization; and A1i, A2i, the random treatment assignments in the first and second stage,
respectively.
In the autism SMART, the primary outcome was collected for all children at each of ni =
4 measurement occasions, occurring 12 weeks apart. So in this example we let tij = tj ∈
{0, 12, 24, 36} denote the time, in weeks, since baseline assessment. In the autism SMART, A1i is
equal to 1 or −1 with equal probability, indicating randomization to either JASP or JASP+AAC.
Among slow responders to JASP, that is, among all subjects with A1i = 1 and Ri = 0, A2i equals
1 or −1 with equal probability, denoting randomization to receive either intensified JASP or the
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AAC device. In the autism study, A2i is not defined for responders and participants randomized
to A1i = −1.
3.2 The model
For the ith participant and for a fixed DTR (a1, a2), consider the following linear mixed effects
model:
Yi(a1, a2) = Xi(a1, a2)β + Zi(a1, a2)bi + i(a1, a2), (3.1)
where β is an unknown p-dimensional parameter, bi is a q-dimensional (q 6 p) latent random
vector (the random effects) with E [bi | Li] = 0 and i(a1, a2) is the ni-length vector of within-
subject residual errors with E [i(a1, a2) | Li] = 0. We also assume that i(a1, a2) is independent
of bi, given Li. The ni× p design matrix Xi(a1, a2) depends on the SMART design and a chosen
model for the mean, conditional on the baseline covariate vector Li. The ni × q random effects
design matrix Zi(a1, a2) is a function of time, Xi(a1, a2), and (a1, a2) chosen so that Zi(a1, a2)bi
models subject-specific deviations from the mean over time. Since (a1, a2) indexes the embedded
DTRs and is not a random variable, Xi(a1, a2) and Zi(a1, a2) are random variables only as a
function of Li. (In this article we do not treat tij as a random variable.) Note that model (3.1)
implies that E [Yi(a1, a2) | Li, bi] = Xi(a1, a2)β+Zi(a1, a2)bi and E [Yi(a1, a2) | Li] = Xi(a1, a2)β.
With model (3.1), we make primary aim comparisons among embedded DTRs based on the lin-
ear, parametric marginal model for E [Yit(a1, a2) | Li] given by βᵀXit(a1, a2), where Xit(a1, a2)ᵀ is
the row of Xi(a1, a2) evaluated at tij = t. This is a marginal mean model in that E [Yit(a1, a2) | Li]
is marginal over both the embedded tailoring variable, Ri(a1), and any other intermediate ran-
dom variables possibly impacted by a1 or (a1, a2). For the autism SMART, an example marginal
mean model used previously (Lu and others, 2016; Almirall and others, 2016) is a piecewise linear
model with a knot at week tj = 12:
βᵀXit(a1, a2) = β0 + t[0,12] (β1 + β2a1) + t(12,36] (β3 + β4a1 + β5I[a1 = 1]a2) + β6agei, (3.2)
where I[·] is the indicator function, t[0,12] = (tI[t 6 12] + 12I[t > 12]), t(12,36] = (t− 12)I[t > 12],
and Li = agei is the mean-centered age at baseline. In this case,
Xit(a1, a2) = [1, t
[0,12], t[0,12]a1, t
(12,36], t(12,36]a1, t
(12,36]I[a1 = 1]a2, agei]
ᵀ.
In this example, the parameters β2, β4, and β5 have a causal interpretation and can be used to
specify the DTR effect estimands of primary interest. An example estimand of primary interest
may be E [Yi24(1, 1)] − E [Yi24(−1, ·)] = 12(2(β2 + β4) + β5), an end-of-treatment comparison
between the DTR with no AAC, (a1, a2) = (1, 1), and the DTR with the highest dose of AAC,
(a1, a2) = (−1, ·). Other DTR effect estimands are similarly formed via linear combinations of
β2, β4, and β5.
In addition to specifying βᵀXit(a1, a2) as a model for E [Yit(a1, a2) | Li], model (3.1) implicitly
defines a working model for the marginal covariance Vi(a1, a2) := Var (Yi(a1, a2) | Li). Since
we assume bi and i(a1, a2) are independent given Li, we have Vi(a1, a2) = Zi(a1, a2)Var(bi |
Li)Zi(a1, a2)
ᵀ + Var(i(a1, a2) |Li). Previously, models for SMARTs with a longitudinal outcome
involved directly specifying a working model for Vi(a1, a2) (Seewald and others, 2018; Almirall
and others, 2016; Lu and others, 2016). In contrast, the working model for Vi(a1, a2) in (3.1) is a
consequence of separately modeling within-subject and between-subject variation via Zi(a1, a2)bi
and i(a1, a2). Together, the variance and covariance structures specified for bi and i(a1, a2) imply
a working model for Vi(a1, a2).
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4. Estimation and prediction
To derive a set of estimating equations for β, we initially consider the following two distributional
assumptions, which are typical for a mixed model like (3.1):
bi | Li ∼ N(0, G) i(a1, a2) | Li ∼ N(0, σ2Ini) (4.3)
With the addition of the assumptions in (4.3), we have Yi(a1, a2) |Li ∼ N(Xi(a1, a2)β, Vi(a1, a2))
with Vi(a1, a2) = Zi(a1, a2)GZi(a1, a2)
ᵀ +σ2Ini . Based on this distribution for Yi(a1, a2) |Li, the
log-likelihood for a sample of N participants under DTR (a1, a2) is
− 1
2
N∑
i=1
log det [Vi(a1, a2)]
− 1
2
N∑
i=1
(Yi(a1, a2)−Xi(a1, a2)β)ᵀVi(a1, a2)−1(Yi(a1, a2)−Xi(a1, a2)β),
(4.4)
In practice, this log-likelihood cannot be maximized since the potential outcomes Yi(a1, a2) are
not observed for all participants under all DTRs in a SMART. Instead, we propose a weighted
pseudo-likelihood based on the observed data collected in a SMART.
4.1 Pseudo-Likelihood Estimation
The log-likelihood (4.4) is a function of the following parameters: β, σ2 and the unique parameters
in G. We let α denote the vector of unique variance parameters in Vi(a1, a2) = Vi(a1, a2;α),
including σ2. For example, if bi is a scalar random variable and Zit(a1, a2) = 1 for all a1, a2 and
t, then α = (σ2,Var(bi |Li)). For brevity, we often suppress notation indicating that Vi(a1, a2) =
Vi(a1, a2;α) depends on α. Given the observed data in a SMART, defined in section 3.1, the
pseudo-likelihood we use to estimate β is
l(β, α) = −1
2
N∑
i=1
∑
a1,a2
W˜i(a1, a2)
(
log det [Vi(a1, a2)] + ri(a1, a2)
ᵀVi(a1, a2)−1ri(a1, a2)
)
, (4.5)
where ri(a1, a2) = ri(a1, a2;β) = Yi−Xi(a1, a2)β and W˜i(a1, a2) = I(a1,a2)i (A1i, Ri, A2i)W (a1,a2)i (Ri).
The indicator I
(a1,a2)
i (A1i, Ri, A2i) is equal to one if and only if the sequence (A1i, Ri, A2i) is
observable under DTR (a1, a2). For example, in the autism SMART, I
(a1,a2)
i (A1i, Ri, A2i) =
I[A1i = a1](Ri + (1 − Ri)I[A2i = a2]), where I[v] equals 1 if the event v occurs and equals zero
otherwise. The design-specific weight W
(a1,a2)
i (Ri) := P (A1i = a1, A2i = a2 |Ri)−1 is an inverse
probability weight for the DTR (a1, a2) which depends on Ri because second-stage random-
ization is restricted according to this binary tailoring variable. In the autism SMART, and in
many two-stage designs, only individuals with Ri = 0 are re-randomized, and W
(a1,a2)
i (Ri) =
1
P(A1i=a1)
[
Ri +
1
P(A2i=a2|A1i=a1,Ri=0) (1−Ri)
]
. (When A2i is not defined for a given value of a1,
we set P (A2i = a2 |A1i = a1, Ri = 0) = 1.)
Differentiating (4.5) with respect to β leads to the following p-dimensional set of estimating
equations:
N∑
i=1
∑
a1,a2
W˜i(a1, a2)Xi(a1, a2)
ᵀVi(a1, a2;α)−1ri(a1, a2;β) = 0, (4.6)
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with the solution
βˆ(α) =
(
N∑
i=1
∑
a1,a2
W˜i(a1, a2)Xi(a1, a2)
ᵀVi(a1, a2;α)−1Xi(a1, a2)
)−1
(
N∑
i=1
∑
a1,a2
W˜i(a1, a2)Xi(a1, a2)
ᵀVi(a1, a2;α)−1Yi
)
.
(4.7)
Substituting βˆ(α) into (4.5), we can obtain estimates of β by first computing αˆ = arg maxα l(βˆ(α), α)
and then estimating β with βˆ := βˆ(αˆ). In the following theorem we derive the asymptotic prop-
erties of βˆ.
Theorem 4.1 Define Ui(β, α) =
∑
a1,a2
W˜i(a1, a2)Xi(a1, a2)
ᵀVi(a1, a2;α)−1(Yi − Xi(a1, a2)β)
and let βˆ(α) be the solution to
∑
i Ui(β, α) = 0 given in (4.7). Assume the following:
i. Correctly specified marginal model: E [Yi(a1, a2) | Li] = Xi(a1, a2)β∗
ii. Sequential randomization: Yi(a1, a2) is independent of A1i given Li; Ri(a1) is independent
of A1i given Li; and Yi(a1, a2) is independent of A2i given (A1i, Ri, Li).
iii. Consistency: Ri = Ri(A1i) =
∑
a1
I[A1i = a1]Ri(a1) and
Yi = RiYi(A1i) + (1−Ri)Yi(A1i, A2i)
=
∑
a1
I[A1i = a1]Ri(a1)Yi(a1) +
∑
a1,a2
I[A1i = a1]I[A2i = a2](1−Ri(a1))Yi(a1, a2),
where RiYi(A1i) := RiYi(A1i, a2) for all a2.
iv. Positivity: P (A1i = a1) > 0 and P (A2i = a2 |A1i, Ri = 0) > 0 for any a1, a2.
v. Regularity conditions: For any given β, αˆ = αˆ(β) converges to some α∗ at
√
N rate, and
sup
β
∥∥∥∥∥ 1N ∑
i
Ui(β, αˆ(β))− lim
N→∞
1
N
∑
i
E [Ui(β, α∗(β)) | Li]
∥∥∥∥∥ P→ 0.
Then βˆ(αˆ) is consistent for β∗ and
√
N(βˆ − β∗) has an asymptotic N(0, J−1IJ−1) distribution,
where I = limN→∞ 1N
∑
i E [Ui(β∗, α∗)Ui(β∗, α∗)ᵀ | Li] and
J = lim
N→∞
1
N
∑
i
E
[∑
a1,a2
W˜i(a1, a2)Xi(a1, a2)
ᵀVi(a1, a2;α∗)−1Xi(a1, a2) | Li
]
.
The diagonal entries of 1N Jˆ
−1Iˆ Jˆ−1 provide approximate standard errors for βˆ, where Iˆ = 1N
∑
i UˆiUˆ
ᵀ
i ,
Uˆi := Ui(βˆ, αˆ) =
∑
(a1,a2)
W˜i(a1, a2)Xi(a1, a2)
ᵀVˆi(a1, a2; αˆ)−1(Yi −Xi(a1, a2)βˆ), and
Jˆ =
1
N
∑
i
∑
a1,a2
W˜i(a1, a2)Xi(a1, a2)
ᵀVˆi(a1, a2; αˆ)−1Xi(a1, a2).
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The proof of Theorem 4.1 is given in the appendix. Note that assumption (ii) and (iv), above,
will be satisfied by design of the SMART, while assumption (iii) connects the observed data to
the potential outcomes. Theorem 4.1 does not require the two assumptions in (4.3) to be true.
These standard distributional assumptions were used only to motivate the pseudo-likelihood and
set of estimating equations which led to an estimator for β.
Given Vi(a1, a2), the estimating equation (4.6) is identical, with slight changes in notation, to
the estimating equation in Lu and others (2016) for the parameters of the marginal mean model.
Estimation of β in Lu and others (2016) differs from our approach primarily in its modeling and
estimation procedure for Vi(a1, a2) = Var(Yi(a1, a2) | Li). In Lu and others (2016), the form of
Vi(a1, a2) (e.g. autoregressive) is proposed by the data analyst and an estimate of Vi(a1, a2) is
obtained via the method of moments. In our case the form of Vi(a1, a2) is a result of specifying
Zi(a1, a2)bi and the variance-covariance of i(a1, a2) and bi, while the estimate of Vi(a1, a2) is
computed by maximizing a weighted pseudo-likelihood.
As in Lu and others (2016), Theorem 4.1 implies that βˆ is consistent for β and has an
asymptotic Gaussian distribution, regardless of whether αˆ converges to the true value of α in
model (3.1). This means that the random effects structure can be misspecified and the estimator
βˆ will remain unbiased. However, the simulation results in Section 5 show that specifying a random
effects structure which more closely models the true subject-to-subject variation in Yi(a1, a2) can
lead to greater efficiency in estimating β. Before demonstrating the performance of our estimator
in simulation studies, we propose a method for predicting the value of bi in model (3.1) and hence
predicting subject-specific trajectories for the primary outcome in a SMART.
4.2 Random Effects Prediction
The estimator for β derived above is all that is necessary for primary aim comparisons among the
DTRs embedded in a SMART. Recall that a secondary motivation for using linear mixed models
is the prediction of subject-specific outcome trajectories under specific DTRs. In this section we
propose a method of predicting bi in (3.1) using the weighted pseudo-likelihood in (4.5).
In Theorem 4.1 we do not require knowledge of Vi(a1, a2) or the distributions of i(a1, a2)
and bi. To predict bi, however, we assume that the distributional assumptions in (4.3) are
true in the population of potential outcomes. Specifically, under model (3.1), assuming (4.3),
(Yi(a1, a2)
ᵀ, bᵀi ) | Li has a multivariate Gaussian distribution, which implies that
bi | Yi(a1, a2), Li ∼ N
(
GZi(a1, a2)
ᵀVi(a1, a2)−1(Yi(a1, a2)−Xi(a1, a2)β), Σb|Y (a1,a2)
)
, (4.8)
where Σb|Y (a1,a2) = Var (bi | Yi(a1, a2), Li). If all potential outcomes Yi(a1, a2) were observed
for each participant, a plug-in estimator of E [bi | Yi(a1, a2), Li] based on (4.8) would serve as a
prediction of bi. Instead, motivated by (4.8), we propose the following:
bˆi(α, β) = arg max
bi
−1
2
∑
a1,a2
W˜i(a1, a2)
(
bi −GZi(a1, a2)ᵀVi(a1, a2)−1(Yi −Xi(a1, a2)β)
)ᵀ
Σ−1b|Y
(
bi −GZi(a1, a2)ᵀVi(a1, a2)−1(Yi −Xi(a1, a2)β)
) (4.9)
=
∑
a1,a2
W˜i(a1, a2)GZi(a1, a2)
ᵀVi(a1, a2;α)−1(Yi −Xi(a1, a2)β)∑
a1,a2
W˜i(a1, a2)
. (4.10)
In practice, the predictions for each participant are obtained by substituting the estimates αˆ
and βˆ into (4.10), so that bˆi := bˆi(αˆ, βˆ). (Recall that estimates for the entries of G are given by
Linear Mixed Models for Sequentially Randomized Trials 9
some of the components of αˆ.) This predictor can be regarded as an empirical Bayes predictor
for bi (Skrondal and Rabe-Hesketh, 2009; Carlin and Louis, 2000) with weights that adjust for
the probability of observing responders and slow responders under each embedded DTR.
5. Simulations studies
Next we use simulation studies to evaluate the ability of our mixed effects model to estimate
causal estimands of primary interest when comparing embedded DTRs in a SMART. We also
compare our mixed model estimator to the GEE-like estimators discussed in Lu and others (2016)
and Seewald and others (2018).
Data were generated from a hypothetical SMART with two treatment stages, two treatment
options for all participants in stage one, and two treatment options for slow responders in stage
two, leading to four embedded DTRs with a1, a2 ∈ {1,−1}. This is a common SMART design
(Naar-King and others, 2016; August and others, 2016, e.g.) and is different from the autism
SMART in Figure 1, in which slow responders from only one of the stage-one treatment arms
were randomized at the start of the second stage. In a given simulation replicate, potential
outcomes were generated according to (C.1), below, and observed data were obtained from these
potential outcomes via randomizations satisfying assumptions (ii) and (iii) in Theorem 4.1. All
simulated participants were randomized with equal probability to either A1i = 1 or A1i = −1,
and only slow responders were randomized to A2i = 1 or A2i = −1 with equal probability.
The potential outcomes in these simulation studies were generated from the following piecewise
linear model:
Yit(a1, a2) = θ0 + I[t 6 κ]t(θ1 + θ2a1) + I[t > κ]κ(θ1 + θ2a1)
+ I[t > κ](t− κ)(θ3 + θ4a1 + (θ5a2 + θ6a1a2)(1−Ri(a1)))
+ I[t > κ](t− κ)(ψ(1)I[a1 = 1] + ψ(−1)I[a1 = −1]) [Ri(a1)− P (Ri(a1) = 1 | Li)]
+ θ7Li + γ0i + γ1it+ it,
(5.11)
where Ri(a1) = I[Yiκ(a1)− θ7Li > c]; c = 1.1; (γ0i, γ1i)ᵀ | Li ∼ N(0,Γ); and it | Li ∼ N(0, τ2)
with τ2 = 1. The binary tailoring variable Ri(a1) is a function of the potential outcome at the
end of the first treatment stage, and the fixed value of c means that P (Ri(a1) = 1 | Li) varies as
a function of a1. The parameters ψ
(1) and ψ(−1) induce a marginal association between Ri(a1)
and second-stage outcomes. The random intercepts and slopes, γ0i and γ1i, induce within-person
correlation, and the residual errors it were generated independently across i and t. The scalar
random variable Li is a binary baseline covariate, and the knot κ represents the time when the
first treatment stage ends. In all simulations, half of the participants were assigned Li = 1 and
half were assigned Li = −1. Under (C.1), the marginal mean can be expressed as follows:
E [Yit(a1, a2) | Li] = βᵀXit(a1, a2) = β0 + I[t 6 κ]t(β1 + β2a1) + I[t > κ] (κ(β1 + β2a1))
+ I[t > κ] ((t− κ)(β3 + β4a1 + β5a2 + β6a1a2)) + β7Li + γ0i + γ1it+ it,
(5.12)
and causal estimands of primary interest are expressed as functions of β2, β4, β5, and β6. Further
details of this generative model are given in the appendix.
Below we present the results of two simulation studies which differ in whether or not they
misspecify the marginal variance and distribution of Yi(a1, a2). In both cases, the linear model
for E [Yi(a1, a2) | Li] is correctly specified. We report estimation performance for the end-of-
study contrast E [Yi3(1,−1) | Li]− E [Yi3(−1,−1) | Li] = 2κβ2 + 2(3− κ)β4 − 2(3− κ)β6, and we
chose simulation parameters so that this contrast had the largest magnitude among any pairwise
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contrast between embedded DTRs. Parameter values for the marginal mean were chosen to
achieve desired values of the standardized effect size d = E[Yi3(1,−1)|Li]−E[Yi3(−1,−1)|Li]√
1
2Var(Yi3(1,−1)|Li)+ 12Var(Yi3(−1,−1)|Li)
.
5.1 Simulation 1
The first simulation study verifies that our estimator βˆ is unbiased in large samples and that large-
sample confidence interval coverage is attained with the standard errors based on Theorem 4.1.
This is accomplished in the ideal setting in which the probability distribution of Yi(a1, a2) |Li can
be correctly specified using our proposed mixed model. In general, Yi(a1, a2) |Li in (C.1) follows
a Gaussian mixture distribution with mixing probability P (Ri(a1) = 0 | Li). However, in this
simulation study we choose 0 = θ5 = θ6 = ψ
(1) = ψ(−1), so that Yit(a1, a2)−E [Yit(a1, a2) | Li] =
γ0i + γ1it + it and the distribution of Yi(a1, a2) | Li is the same as the marginal distribution
specified in the following mixed model:
Yit(a1, a2) | b0i, b1i, Li ∼ N(βᵀXit(a1, a2) + b0i + b1it, σ2), (b0i, b1i)ᵀ | Li ∼ N(0, G), (5.13)
where βᵀXit(a1, a2) is the linear parametrization of the mean in equation (5.12). We compared
this “slopes and intercepts” mixed model, in which the joint distribution of Yi(a1, a2) | Li is
correctly specified, to an “intercepts only” mixed model,
Yit(a1, a2) | b0i, Li ∼ N(βᵀXit(a1, a2) + b0i, σ2), b0i | Li ∼ N(0,Var (b0i)), (5.14)
in which Var(Yi(a1, a2) | Li) is misspecified. We use different notation for the random effects
and variance parameters in (5.13)–(5.14) than we do in (C.1) to distinguish models used for
estimation from the true, data-generating probability distribution. In this simulation study we
set Var (γ0) = 0.8,Var (γ1) = 1 and Cov(γ0, γ1) = −0.2.
Table 2 contains the bias and standard deviation of the point estimates, the mean of the
approximate standard errors, the coverage probability for a 95-percent confidence interval, and
the root mean squared error (RMSE) computed from 1,000 simulation replicates. In large samples,
the bias is approximately two orders of magnitude smaller than the standard deviation of the point
estimates, confirming that the mixed model estimator is unbiased for the linear mean parameters
in (5.12). The standard errors based on Theorem 4.1 provide confidence interval coverage close to
the nominal level in large samples. In addition, note that the intercepts only mixed model, which
misspecifies Var(Yi(a1, a2) |Li), does not introduce bias in large samples. Instead, the estimator is
slightly less efficient than the slopes and intercepts model, in which both the mean and covariance
of Yi(a1, a2) are correctly specified.
5.2 Simulation 2
In this second simulation, we investigate whether the estimator βˆ is unbiased in large samples,
and whether this estimator can provide efficiency gains relative to existing estimators, in a more
realistic scenario in which it is not possible to correctly specify the distribution of Yi(a1, a2) | Li
using model (3.1). Data were again generated from model (C.1), but the coefficients θ5, θ6, ψ
(1)
and ψ(−1) were nonzero and therefore Yi(a1, a2)|Li had a marginal Gaussian mixture distribution.
In addition to the mixed models (5.13)–(5.14), we also report estimation performance of the
GEE-like estimator of Lu and others (2016) and Seewald and others (2018). With these GEE
estimators, a working model for Vi(a1, a2) (e.g. exchangeable) is specified directly and the method
of moments is used to estimate the parameters in this working model. A complete description of
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our implementation of these GEE estimators is given in the appendix. In this simulation study,
all of the models used for estimation correctly specify the linear model βᵀXit(a1, a2), but none
of them correctly specify the marginal covariance or the distribution of Yi(a1, a2) | Li.
Table 3 compares the two mixed models and the GEE estimator with exchangeable, unstruc-
tured, and independence working models for Vi(a1, a2) in their ability to estimate the end-of-study
contrast with standardized effect size d ≈ 0.5. The magnitude of the bias relative to the standard
deviation in Table 3 indicates that all of these estimators are unbiased in large samples.
While none of the estimation models in this simulation study correctly specify Vi(a1, a2), we
can see in Table 3 that efficiency (measured by RMSE) is improved by a working model which
more closely resembles the true marginal covariance. Here we report RMSE as a fraction of the
smallest RMSE for a fixed sample size. To measure the performance of each working model for
Vi(a1, a2), we report
‖Vtrue−E[Vˆ ]‖
‖Vtrue‖ , the relative error in the Frobenius norm between Vtrue :=
1
4
∑
a1,a2
Vi(a1, a2), the true average covariance matrix of Yi(a1, a2) according to the generative
model, and the simulation-based estimate of E
[
Vˆ
]
:= 14
∑
a1,a2
E
[
Vˆi(a1, a2; αˆ)
]
, the large-sample
average covariance matrix implied by the estimation model. The slopes and intercepts mixed
model had both the lowest relative error in estimating Vtrue and the lowest RMSE for each fixed
sample size. For these estimators, RMSE decreases as the working model for Vi(a1, a2) improves.
This simulation study suggests that if the separate specification of between-person and within-
person variation in a mixed effects model leads to improved modeling of the marginal covariance,
we can expect efficiency gains over GEE-like approaches when comparing embedded DTRs.
6. Application
Finally, we demonstrate our mixed model using the autism SMART of Kasari and others (2014).
Our goal here is to compare the three embedded DTRs based on changes in communication
outcomes for the children receiving each DTR. Figure 2 displays the measured primary outcome,
the number of socially communicative utterances, for each participant in this study at baseline
and at weeks 12, 24, and 36. For the marginal mean, we specified the piecewise linear model (3.2),
and we specified random intercepts as the random effects structure.
The parameter vector β = (β0, . . . , β6) was estimated as described in Section 4.1 using widely
available software for linear mixed models (Bates and others, 2015) applied to a restructured
version of the observed data. This software implementation is described in greater detail in
the appendix. The estimates of α and β obtained in this manner were then used to compute
estimated standard errors as described in Section 4.1. Table 4 displays the estimated coefficients
in this model with 95-percent confidence intervals, and Figure 3 displays the estimated marginal
mean for each DTR at each time point,
To understand whether we have evidence that communication outcomes differ among children
receiving each of these DTRs, we performed an “omnibus” test of whether the three DTRs differ
at all. We tested the hypothesis that the area under the curve (AUC) for the marginal mean is the
same across all three DTRs, which, in this case, is equivalent to testing H0 : Mβ = 0 for a constant
matrix M . Based on Theorem 4.1, under H0, the statistic (Mβˆ)
ᵀ
(
M ΣˆβM
ᵀ
)−1
Mβˆ, where Σˆβ is
the estimated covariance matrix of βˆ, has a χ2 distribution with two degrees of freedom in large
samples. This test statistic was equal to 10.32 with a p-value of 0.006, suggesting differences in
the AUCs among the three DTRs. Following this omnibus test, we examined pairwise contrasts
between each DTR at each time point, given in Figure 4, which suggest that the DTR which
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starts with the AAC speech device is superior to the other two DTRs, at least during the first
12 weeks.
For demonstration, Figure 5 displays predicted person-specific trajectories, βˆᵀXit(a1, a2)+ bˆi,
using the intercepts-only mixed model, along with the observed outcomes and the estimated mean
outcome under each DTR. This display could be used to assess subject-to-subject variation rela-
tive to the estimated mean under each DTR or to identify individuals with outlying trajectories
based on the fitted model. In this example, random intercepts lead to subject-specific trajectories
which are parallel to the estimated mean under each DTR. The potential high outliers under the
DTRs (JASP, AAC) and (AAC, AAC+) could be investigated to help characterize the variation
in communication outcomes for these study participants.
7. Discussion
In Section 4.2 we proposed a method for predicting random effects based on a weighted pseudo-
likelihood. The prediction method we propose is analogous to the “best linear unbiased predic-
tors” commonly used in standard mixed effects analysis of longitudinal data (Robinson, 1991;
Verbeke and Molenberghs, 2009, Section 7.4). However, our proposed predictor bˆi is a nonlinear
function of (A1i, RiA2i) across all i, and it is unclear whether bˆi has minimum mean squared error
(MSE) marginally over these random variables. Further work is needed to derive a minimum-
MSE property for bˆi which is marginal over (A1i, Ri, A2i) and uses the same statistical and causal
assumptions of Theorem 4.1.
This article focused on marginal mean models for the embedded DTRs that are conditional
only on baseline covariates. This is analogous to primary aim analyses in standard randomized
trials. An alternative approach would be to specify a mixed model conditional on both the baseline
covariates and the embedded tailoring variables. For example, in the autism SMART, one could
propose a mixed effects model for Yi conditional on A1i, Ri, A2i. Future work will investigate how
to obtain consistent estimators for marginal estimands using this kind of conditional modeling of
the observed longitudinal outcome.
In addition to the reasons given in Section 1, scientists might prefer mixed effects models
because they may require less restrictive assumptions about missing data, at least when the true
probability distribution for the observed data is correctly specified (Hedeker and Gibbons, 2006,
Ch. 14; Fitzmaurice and others, 2012, Ch. 17) Our marginal modeling and weighted, pseudo-
likelihood estimation approach does not require a correct specification of the true probability
distribution that generated the observed data. Additional work is needed to understand whether
our marginal model for longitudinal SMARTs enjoys the purported benefits of standard mixed
models in the presence of missing data. In the appendix we present simulation results which
suggest that our mixed model may offer some protection against bias in the presence of ignorable
missing data.
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Table 1. The dynamic treatment regimens embedded in the example autism SMART. The last
column provides the known inverse probability weight for subjects in each of the cells A–E in
Figure 1.
First-stage Status at end Second-stage Cell in Known
DTR Label (a1, a2) Treatment of first-stage Treatment Figure IPW
(JASP, JASP+) (1, 1) JASP
Responder Continue JASP A 2
Slow Responder Intensify JASP B 4
(JASP, AAC) (1,−1) JASP Responder Continue JASP A 2
Slow Responder Augment JASP+AAC C 4
(AAC, AAC+) (−1, ·) JASP+AAC Responder Continue JASP+AAC D 2
Slow Responder Intensify JASP+AAC E 2
Table 2. Estimation performance of an end-of-study contrast with two mixed model specifications
when the population of potential outcomes exactly follows the marginal distribution implied by the
slopes and intercepts mixed model. The intercepts only model specifies the correct mean model
but is otherwise misspecified. Values compuuted from 1,000 simulation replicates. The nominal
confidence level was 95 percent.
Method d True value N Bias
Monte
Carlo SD
SE
Estimate
CI
Coverage
RMSE
LMM slopes and intercepts 0.2 0.600 50 -0.102 1.222 1.119 0.911 1.226
200 -0.018 0.659 0.629 0.931 0.659
1000 0.010 0.296 0.290 0.945 0.296
5000 -0.002 0.132 0.130 0.945 0.132
0.8 2.480 50 0.071 1.228 1.117 0.905 1.229
200 -0.002 0.661 0.623 0.932 0.661
1000 -0.008 0.285 0.286 0.950 0.285
5000 -0.007 0.129 0.128 0.948 0.129
LMM intercepts only 0.2 0.600 50 -0.018 1.338 1.196 0.886 1.338
200 0.001 0.748 0.694 0.917 0.748
1000 0.010 0.336 0.323 0.938 0.336
5000 0.002 0.146 0.145 0.951 0.146
0.8 2.480 50 0.148 1.339 1.191 0.888 1.346
200 0.011 0.728 0.682 0.922 0.727
1000 -0.006 0.312 0.317 0.957 0.311
5000 -0.005 0.143 0.142 0.957 0.143
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Table 3. Simulation 2: Estimation of an end-of-study contrast with true value 2.1197 and stan-
dardized effect size d ≈ 0.5. Values computed from 1,000 simulation replicates. The nominal
confidence level was 95 percent. RMSE inflation is the ratio of the RMSE to the smallest RMSE
among the five methods for a fixed sample size.
N Method Bias
Monte
Carlo SD
SE
Estimate
CI
Coverage
RMSE
Inflation
‖Vtrue−E[Vˆ ]‖
‖Vtrue‖
50 LMM slopes and intercepts 0.013 1.655 1.505 0.910 1.000 0.051
GEE Unstructured 0.064 1.761 1.452 0.854 1.064 0.107
LMM intercepts only 0.115 1.922 1.656 0.871 1.163 0.640
GEE Exchangeable 0.114 1.924 1.651 0.870 1.164 0.643
GEE Independence 0.182 2.163 1.804 0.861 1.311 0.900
200 LMM slopes and intercepts -0.041 0.842 0.839 0.938 1.000 0.015
GEE Unstructured -0.019 0.878 0.822 0.925 1.042 0.028
LMM intercepts only 0.002 0.983 0.951 0.930 1.167 0.638
GEE Exchangeable 0.002 0.984 0.950 0.931 1.167 0.638
GEE Independence 0.016 1.099 1.055 0.936 1.305 0.900
1000 LMM slopes and intercepts -0.006 0.396 0.385 0.948 1.000 0.009
GEE Unstructured -0.003 0.410 0.384 0.933 1.034 0.011
LMM intercepts only 0.011 0.442 0.439 0.950 1.115 0.637
GEE Exchangeable 0.011 0.442 0.439 0.949 1.115 0.637
GEE Independence 0.021 0.483 0.489 0.950 1.220 0.900
5000 LMM slopes and intercepts 0.000 0.172 0.174 0.958 1.000 0.007
GEE Unstructured -0.001 0.178 0.174 0.947 1.039 0.007
LMM intercepts only 0.005 0.204 0.198 0.936 1.191 0.637
GEE Exchangeable 0.005 0.204 0.198 0.936 1.191 0.637
GEE Independence 0.005 0.227 0.221 0.947 1.323 0.900
Table 4. Coefficient estimates, standard errors (SE) and 95-percent confidence intervals from the
random intercepts mixed model for the autism SMART.
Coefficient Estimate SE 95% CI
β0 28.885 3.763 (21.509, 36.261)
β1 1.501 0.315 (0.885, 2.118)
β2 −0.929 0.287 (−1.492,−0.367)
β3 0.112 0.174 (−0.229, 0.452)
β4 0.23 0.174 (−0.111, 0.571)
β5 −0.111 0.137 (−0.38, 0.158)
β6 −4.514 2.777 (−9.957, 0.93)
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R
Fig. 1. Schematic of an example sequential multiple-assignment randomized trial (SMART) for children
with ASD who are minimally verbal. JASP stands for joint attention social play intervention; AAC stands
for alternative and augmentative communication. The encircled R signifies randomization; randomiza-
tions occurred at baseline and at the end of week 12 following identification of responder status. A child
was considered a responder if there is a 25% or greater improvement on 7 or more (out of 14) language
measures; otherwise, the child was labeled a slow responder.
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Fig. 2. Measured number of socially communicative utterances for the N = 61 children in the autism
SMART. Responders to either first-stage treatment continued that treatment. Dashed lines in the
upper-left panel correspond to slow responders to initial JASP who were randomly assigned to receive
JASP+AAC in the second stage. All other slow responders received an intensified version of the initial
treatment.
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Fig. 3. Estimated marginal mean, at age 6.3 (the average age of participants in the study), for the three
treatment regimens in the autism SMART.
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Fig. 4. Pairwise contrasts with 95-percent pointwise confidence intervals for the autism SMART.
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Fig. 5. Person-specific predicted trajectories using the intercepts-only model for the autism SMART (top
row) along with observed number of socially communicative utterances (bottom row). Bold lines are the
estimated marginal mean trajectories under each DTR for children at age 6.3, the average age of the study
participants. Responders to initial treatment with JASP are observable under both (JASP, JASP+) and
(JASP, AAC), and the observed and predicted trajectories for these participants are displayed for both
of these regimens.
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APPENDIX
This appendix contains the following: a proof of Theorem 4.1; further description of the GEE
estimator used as a comparison method in the simulation studies in Section 5; results of a simula-
tion study with ignorable missing data; and a description of how the weighted pseudo-likelihood
was implemented with standard mixed models software for the analysis in Section 6.
A. Proof of Theorem 4.1
First note that
∑
i Ui(βˆ, αˆ) = 0, Ri(1 − Ri) = 0, R2i = Ri and (1 − Ri)2 = 1 − Ri. To simplify
notation, we suppress dependence of Xi(a1, a2) and Vi(a1, a2;α
∗) on (a1, a2). Then, by definition
of W˜i(a1, a2),
E
[
W˜i(a1, a2)X
ᵀ
i Vi(α
∗)−1(Yi −Xiβ∗) | Li
]
= E
[
I[A1i = a1]
P (A1i = a1)
(
Ri +
I[A2i = a2]
P (A2i = a2 |A1i = a1, Ri = 0)(1−Ri)
)
×Xᵀi Vi(α∗)−1(Yi −Xiβ∗) | Li
]
,
(A.1)
and, using consistency assumption (ii)
= E
[
I[A1i = a1]
P (A1i = a1)
RiX
ᵀ
i Vi(α
∗)−1(RiYi(A1i)−Xiβ∗) | Li
]
+ E
[
I[A1i = a1]
P (A1i = a1)
I[A2i = a2]
P (A2i = a2|A1i = a1, Ri = 0)(1−Ri)
×Xᵀi Vi(α∗)−1(Yi(A1i, A2i)−Xiβ∗) | Li
]
.
(A.2)
Next note that I[A2i = a2]Yi(A1i, A2i) = I[A2i = a2]Yi(A1i, a2) and, by assumption (iii),A2i |= Y (a1, a2)|
A1i, Ri for any fixed regime (a1, a2). Let Q = P (A1i = a1)−1 P (A2i = a2 |A1i = a1, Ri = 0)−1.
E
[
QI[A1i = a1]I[A2i = a2](1−Ri)Xᵀi Vi(α∗)−1(Yi(A1i, A2i)−Xiβ∗) | Li
]
(A.3)
= E
{
QI[A1i = a1]E
[
I[A2i = a2](1−Ri)Xᵀi Vi(α∗)−1(Yi(A1i, A2i)−Xiβ∗) |A1i, Ri
] | Li}
(A.4)
= E
{
QI[A1i = a1]E
[
I[A2i = a2](1−Ri)Xᵀi Vi(α∗)−1(Yi(A1i, a2)−Xiβ∗) |A1i, Ri = 0
] | Li}
(A.5)
= E
{
I[A1i = a1]
P (A1i = a1)
E
[
(1−Ri)Xᵀi Vi(α∗)−1(Yi(A1i, a2)−Xiβ∗) |A1i, Ri = 0
] | Li} (A.6)
Substituting into equation (A.2),
(A.2) =E
[
I[A1i = a1]
P (A1i = a1)
RiX
ᵀ
i Vi(α
∗)−1(RiYi(A1i)−Xiβ∗) | Li
]
+ E
[
I[A1i = a1]
P (A1i = a1)
(1−Ri)Xᵀi Vi(α∗)−1(Yi(A1i, a2)−Xiβ∗) | Li
] (A.7)
=Xᵀi Vi(α
∗)−1 E [Ri(a1)Yi(a1) + (1−Ri(a1))Yi(a1, a2)−Xiβ∗ | Li] (A.8)
=0 (A.9)
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where (A.8) is obtained from the consistency assumption on Ri and independence of A1i and
R(a1). Thus E [
∑
i Ui(β
∗, α∗)] = 0. Under Assumption (v), we have that βˆ is a consistent esti-
mator of β∗. To derive the asymptotic distribution of βˆ, note that
√
N(βˆ − β∗) = −
(
1
N
d
∑
i Ui(β, αˆ(β))
dβ
∣∣∣
β=β∗
+ oP (1)
)−1
1√
N
∑
i
Ui(β
∗, αˆ(β∗))
The result follows using similar arguments as those in the proof of Theorem 2 in Liang and Zeger
(1986).
B. Details of the GEE estimator used in simulation
Here we describe the GEE-like estimator of Lu and others (2016) and Seewald and others (2018)
used as a comparison method in the simulations in Section 5.
First, an initial least squares estimate is computed:
βˆ(0) =
(∑
i
∑
a1,a2
W˜i(a1, a2)Xi(a1, a2)
ᵀXi(a1, a2)
)−1(∑
i
∑
a1,a2
W˜i(a1, a2)Xi(a1, a2)
ᵀYi
)
.
This initial estimate is used to compute the residual vectors r
(0)
i (a1, a2) = Yi−Xi(a1, a2)βˆ(0) for
all i and (a1, a2).
Next we compute method of moments estimators for Vi(a1, a2). Let D be the number of
embedded DTRs, i.e. D =
∑
a1,a2
1. For t 6= s, define the following:
σˆ2t (a1, a2) =
∑
i W˜i(a1, a2)r
(0)
it (a1, a2)
2
Nt
σˆ2(a1, a2) =
Ntσˆ
2
t (a1, a2)∑
tNt
σˆ2t =
1
D
∑
a1,a2
σˆ2t (a1, a2) σˆ
2 =
1
D
∑
a1,a2
σˆ2(a1, a2)
ρˆts(a1, a2) =
1
Nts
∑
i
W˜i(a1, a2)
[
r
(0)
it (a1, a2)r
(0)
is (a1, a2)
σˆt(a1, a2)σˆs(a1, a2)
]
, ρˆts =
1
D
∑
a1,a2
ρˆts(a1, a2)
ρˆ(a1, a2) =
1
N
∑
i
W˜i(a1, a2)
ni(ni − 1)/2
∑
s<t
r
(0)
is (a1, a2)r
(0)
it (a1, a2)
σˆs(a1, a2)σˆt(a1, a2)
, ρˆ =
1
D
∑
a1,a2
ρˆ(a1, a2)
ψˆ(a1, a2) =
1
N
∑
i
W˜i(a1, a2)
ni(ni − 1)/2
∑
s<t
r
(0)
is (a1, a2)r
(0)
it (a1, a2)
σˆ2(a1, a2)
, ψˆ =
1
D
∑
a1,a2
ψˆ(a1, a2)
where Nt is the number of individuals with an observation at unique time point t and Nts is the
number of individuals with observations at both of the time points t and s. The estimators defined
above are simply the method of moments estimators for correlation or variance parameters at each
observation. They differ in whether the variances or correlations are assumed to be equal across
DTRs and in whether the variance is assumed to be constant as a function of time. By combining
these correlation and variance estimators, we can obtain various working models for Vi(a1, a2).
For example, the unstructured and exchangeable estimates of Vi(a1, a2) have the following entries,
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vts(a1, a2):
Unstructured vtt(a1, a2) = σˆ
2
t Exchangeable vtt(a1, a2) = σˆ
2 for all t
vts(a1, a2) = σˆsσˆtρˆts vts(a1, a2) = ψˆσˆ
2
for all a1, a2 for all a1, a2
The independence working model sets all off-diagonal entries of Vi(a1, a2) to zero and all diagonal
entries to σˆ2.
Autoregressive working models for Vi(a1, a2) are also possible using the following correlation
estimators:
τˆt(a1, a2) =
1
N
∑
i
W˜i(a1, a2)
ni − 1
ni−1∑
s=1
r
(0)
is (a1, a2)r
(0)
i(s+1)(a1, a2)
σˆs(a1, a2)σˆs+1(a1, a2)
τˆt =
1
D
∑
a1,a2
τˆt(a1, a2)
τˆ(a1, a2) =
1
N
∑
i
W˜i(a1, a2)
ni − 1
ni−1∑
s=1
r
(0)
is (a1, a2)r
(0)
i(s+1)(a1, a2)
σˆ2(a1, a2)
τˆ =
1
D
∑
a1,a2
τˆ(a1, a2)
C. Details of the generative model used in simulation
This section provides more detail about the generative model used in the simulation studies in
Section 5.
The potential outcomes were generated from the following piecewise linear model:
Yit(a1, a2) =
θ0 + I[t 6 κ]t(θ1 + θ2a1) + I[t > κ]κ(θ1 + θ2a1)
+ I[t > κ](t− κ)(θ3 + θ4a1 + (θ5a2 + θ6a1a2)(1−Ri(a1)))
+ I[t > κ](t− κ)(ψ(1)I[a1 = 1] + ψ(−1)I[a1 = −1]) [Ri(a1)− P (Ri(a1) = 1 | Li)]
+ θ7Li + γ0i + γ1it+ it,
(C.1)
where Ri(a1) = I[Yiκ(a1)− θ7Li > c]; c = 1.1; θ7 = −0.2; (γ0i, γ1i)ᵀ ∼ N(0,Γ); it ∼ N(0, τ2)
with τ2 = 1; t ∈ {0, 0.5, 1.5, 2, 2.25, 2.5, 3}; and κ = 2.
Under model (C.1),
Yit(a1, a2)− E [Yit(a1, a2) | Li]
= γ0 + γ1t+ t
+ I[t > κ](t− κ)θ5a2 [(1−Ri(a1))− P (Ri(a1) = 0 | Li)]
+ I[t > κ](t− κ)θ6a1a2 [(1−Ri(a1))− P (Ri(a1) = 0 | Li)]
+ I[t > κ](t− κ)
(
ψ(1)I[a1 = 1] + ψ(−1)I[a1 = −1]
)
[Ri(a1)− P (Ri(a1) = 1 | Li)] ,
(C.2)
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and we can parameterize this marginal mean model as follows:
E [Yit(a1, a2) | Li] = βᵀXit(a1, a2) = β0 + I[t 6 κ]t(β1 + β2a1) + I[t > κ]κ(β1 + β2a1)
+ I[t > κ](t− κ)(β3 + β4a1 + β5a2 + β6a1a2)
+ β7Li,
(C.3)
where βj = θj for j ∈ {0, 1, 2, 3, 4, 7} and
β5 =
{
θ5
(
pi(1)
2
+
pi(−1)
2
)
+ θ6
(
pi(1)
2
− pi
(−1)
2
)}
β6 =
{
θ5
(
pi(1)
2
− pi
(−1)
2
)
+ θ6
(
pi(1)
2
+
pi(−1)
2
)}
.
Next, we derive the marginal covariance and variance of the repeated measures outcomes
under this generative model. These marginal covariances and variances are used to calculate the
population standardized effect size
d =
E [Yi3(1,−1) | Li]− E [Yi3(−1,−1) | Li]√
1
2Var (Yi3(1,−1) | Li) + 12Var (Yi3(−1,−1) | Li)
.
Let Wit = z
ᵀ
itγ + it and zit = (1, t)
ᵀ. Then
Cov [Yit(a1, a2), Yis(a1, a2) | Li]
= zᵀitGzis + τ
2I[s = t]
−
(
C
(a1)
1 (s) + C
(a1,a2)
2 (s)− C(a1)3 (s)
)
(1− pi(a1))E [Wit |Ri(a1) = 1, Li]
−
(
C
(a1)
1 (t) + C
(a1,a2)
2 (t)− C(a1)3 (t)
)
(1− pi(a1))E [Wis |Ri(a1) = 1, Li]
+
(
C
(a1)
1 (t) + C
(a1,a2)
2 (t)− C(a1)3 (t)
)(
C
(a1)
1 (s) + C
(a1,a2)
2 (s)− C(a1)3 (s)
)
pi(a1)(1− pi(a1))
(C.4)
where
C
(a2)
1 (t) = I[t > κ](t− κ)θ5a2
C
(a1,a2)
2 (t) = I[t > κ](t− κ)θ6a1a2
C
(a1)
3 (t) = I[t > κ](t− κ)(ψ(1)I[a1 = 1] + ψ(−1)I[a1 = −1]).
Note that
E [Wit |Ri(a1) = 1, Li] = E [Wit |Wiκ > c− θ0 − κ(θ1 + θ2a1), Li] ,
(Wit,Wiκ)
ᵀ | Li ∼ N
([
0
0
]
,
[
zᵀitGzit + τ
2, zᵀitGziκ + Cov(it, iκ | Li)
· · · zᵀiκGziκ + τ2
])
,
and since (Wit,Wiκ)
ᵀ | Li is bivariate Gaussian, E [Wit |Wiκ > c− θ0 − κ(θ1 + θ2a1), Li] can be
computed using the truncated multivariate Gaussian distribution.
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D. Additional simulation study
One potential benefit of mixed models is their ability to provide unbiased parameter estimates
when data are missing at random, assuming that estimation and inference are based on a correctly
specified likelihood for the observed data (Fitzmaurice and others, 2012, Ch. 17; Hedeker and
Gibbons, 2006, Ch. 14; Molenberghs and Kenward, 2007, Ch. 7; Gibbons and others, 2010). In
the case of the mixed model we propose for longitudinal SMARTs, estimation and inference are
based on a weighted pseudo-likelihood, not the true likelihood for the observed data, so it is not
clear whether bias can be avoided with ignorable missing data in a SMART.
To help understand whether mixed models provide any protection against bias due to missing
data in a longitudinal SMART, this additional simulation study describes the performance of
our mixed model and the GEE-like estimators of Seewald and others (2018) and Lu and others
(2016) when data are missing at random (ignorable) due to study dropout. In this scenario,
if a participant’s observed Yit at t = 2.25 was less than −3.5, then all observations from that
participant at time points t > 2.5 were discarded. This results in about 20 percent dropout among
participants with (A1i, A2i, Ri) = (−1,−1, 0); about 17 percent dropout among participants
with (A1i, A2i, Ri) = (−1, 1, 0); about nine and ten percent dropout among participants with
(A1i, A2i, Ri) = (1, 1, 0) and (1,−1, 0), respectively; and less than 0.1 percent dropout among
participants with Ri = 1.
Table 5 compares the same estimators from Simulation 2 in the Section 5 in their ability
to estimate an end-of-study contrast with effect size d ≈ 0.5 in the presence of the dropout
process described above. In this scenario, we see bias in large samples, although the degree
of bias decreases as
‖Vtrue−E[Vˆ ]‖
‖Vtrue‖ decreases. This suggests that the ability of a mixed model to
flexibly model Vi(a1, a2), and to efficiently estimate Vi(a1, a2), may provide some protection
against bias due to ignorable missing data. Since we are not able to fit a mixed model using
the true likelihood for the potential outcomes, the purported benefits of mixed models in the
presence of ignorable missing data (compared to GEE approaches) might not exist when analyzing
longitudinal SMARTs.
E. Software implementation with integer-valued weights
Next we describe how the mixed model for longitudinal SMARTs can be implemented using
standard mixed model software, such as Bates and others (2015). This implementation is limited
to analyses in which the weights W
(a1,a2)
i (Ri) are integer-valued. When estimating these proba-
bility of treatment weights (Hirano and others, 2003; Brumback, 2009) or when randomization
probabilities are unequal across treatment options, the weights may not be integer-valued. Future
work will develop software implementations for use in SMART designs beyond the special case
of integer-valued weights.
Recall that I(a1,a2)(A1i, Ri, A2i) is an indicator of whether subject i is observable under reg-
imen (a1, a2). For example, in the autism study, I
(a1,a2)(A1i, Ri, A2i) = I[A1i = a1](Ri + (1 −
Ri)I[A2i = a2]). Let f(a1, a2, Yi, Li) be an arbitrary function of the observed response vector Yi,
baseline covariates Li, and the DTR (a1, a2). In the autism SMART and other common designs,
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responders (Ri = 1) are observable under both of the DTRs (A1i, 1), (A1i,−1). In this case,
N∑
i=1
∑
a1,a2
I(a1,a2)(A1i, Ri, A2i)W
(a1,a2)
i (Ri)f(a1, a2, Yi, Li)
=
∑
i:Ri=1
W
(A1i,1)
i (1)f(A1i, 1, Yi, Li) +
∑
i:Ri=1
W
(A1i,−1)
i (1)f(A1i,−1, Yi, Li)
+
∑
i:Ri=0
W
(A1i,A2i)
i (0)f(A1i, A2i, Yi, Li),
(E.1)
since when Ri = 0, subject i is observable under DTR (A1i, A2i) only.
The weighted pseudo-likelihood is
l(β, α) = −1
2
N∑
i=1
∑
a1,a2
W˜i(a1, a2) log det [Vi(a1, a2)]
− 1
2
∑
i
∑
a1,a2
W˜i(a1, a2)ri(a1, a2)
ᵀVi(a1, a2)−1ri(a1, a2)
(E.2)
= −1
2
∑
i:Ri=1
W
(A1i,1)
i (1) log det [Vi(A1i, 1)]
− 1
2
∑
i:Ri=1
W
(A1i,−1)
i (1) log det [Vi(A1i,−1)]
− 1
2
∑
i:Ri=0
W
(A1i,A2i)
i (0) log det [Vi(A1i, A2i)]
− 1
2
∑
i:Ri=1
W
(A1i,1)
i (1)(Yi −Xi(A1i, 1)β)ᵀVi(A1i, 1)−1(Yi −Xi(A1i, 1)β)
− 1
2
∑
i:Ri=1
W
(A1i,−1)
i (1)(Yi −Xi(A1i,−1)β)ᵀVi(A1i,−1)−1(Yi −Xi(A1i,−1)β)
− 1
2
∑
i:Ri=0
W
(A1i,A2i)
i (0)(Yi −X(A1i,A2i)i β)ᵀVi(A1i, A2i)−1(Yi −X(A1i,A2i)i β)
(E.3)
This objective function is equivalent to the log-likelihood in a linear mixed effects model
based on an “augmented” data set constructed in the following manner. For all subjects i whose
observed data are observable under more than one DTR, duplicate the baseline covariates Li and
response vectors Yi once for each of those DTRs. In the autism SMART, subjects with Ri = 1
are observable under (A1i, 1) and (A2i,−1), so the baseline covariates and response vectors are
duplicated twice. The design matrices Xi(a1, a2) and Zi(a1, a2) for each replicate are formed
by plugging in the values of (a1, a2) corresponding to the DTR under which that replicate is
observable. The weights for these replicates are formed similarly. Thus, for a subject with Ri = 1,
the augmented data consist of{
Xi(A1i, 1), Zi(A1i, 1)Li, Yi,W
(A1i,1)
i (1)
}
{
Xi(A1i,−1), Zi(A1i,−1), Li, Yi,W (A1i,−1)i (1)
}
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For subjects whose observed data are observable only under the DTR (A1i, A2i), their observed
data are unchanged and included in the augmented data set.
Indexing the artificial “subjects” in the augmented data set by s = 1, . . . ,M , we have, based
on (E.3),
l(β, α) = −1
2
M∑
s=1
Ws log det [Vs]− 1
2
M∑
s=1
Ws(Ys −Xsβ)ᵀV −1s (Ys −Xsβ), (E.4)
where Ws, Xs and Vs are the values of W
(A1i,A2i)
i (Ri), Xi(a1, a2) and Vi(a1, a2) evaluated under
the DTR corresponding to replicate s in the augmented data. Thus, to find maximum likelihood
estimates of the parameters β and α, we can use any software package which maximizes a weighted
log-likelihood of the form (E.4). In particular, when Ws is an integer, we can maximize (E.4)
by duplicating all of the terms indexed by s a total of Ws times and fitting the mixed model
corresponding to (E.4) without the use of weights.
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Table 5. Simulation 3: Estimation performance with ignorable missing data due to study dropout.
The true contrast value is 2.1197, corresponding to a standardized effect size of d ≈ 0.5. Values
computed from 1,000 simulation replicates. The nominal confidence level was 95 percent.
N Method Bias
Monte
Carlo SD
SE
Estimate
CI
Coverage
RMSE Inflation
‖Vtrue−E[Vˆ ]‖
‖Vtrue‖
200 LMM slopes and intercepts -0.066 0.887 0.836 0.929 1.000 0.046
GEE Unstructured -0.127 0.900 0.789 0.906 1.023 0.257
LMM intercepts only -0.401 0.950 0.891 0.900 1.161 0.660
GEE Exchangeable -0.402 0.951 0.890 0.900 1.161 0.663
GEE Independence -0.559 1.047 0.983 0.881 1.335 0.904
1000 LMM slopes and intercepts -0.103 0.389 0.381 0.939 1.000 0.044
GEE Unstructured -0.158 0.396 0.366 0.902 1.059 0.246
LMM intercepts only -0.445 0.419 0.408 0.796 1.519 0.659
GEE Exchangeable -0.445 0.419 0.408 0.795 1.519 0.661
GEE Independence -0.612 0.464 0.451 0.699 1.907 0.904
5000 LMM slopes and intercepts -0.080 0.177 0.171 0.921 1.000 0.042
GEE Unstructured -0.138 0.178 0.165 0.848 1.157 0.243
LMM intercepts only -0.437 0.187 0.184 0.349 2.448 0.658
GEE Exchangeable -0.437 0.187 0.184 0.350 2.448 0.660
GEE Independence -0.614 0.204 0.203 0.134 3.332 0.904
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